Join Growin Stock Community!
Beta
Back to ABNB.US Analysis

Ticker

Value

empty

There is no following symbol in this watchlist.

  • EPS
  • EPS Diluted
  • Revenue
  • Operation Income
  • Net Income
  • Operating Expenses
  • Cash Flow
  • Cash & Debt
  • Current Contract Liabilities
operating-expenses-chart

ABNB Operating Expenses

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

In Q1'26, ABNB's operating expenses reached $1.68B USD, with R&D expenses at $638M USD and SG&A expenses at $1.05B USD, marking a sequential increase from Q4'25's total of $1.69B USD driven primarily by higher R&D investments. From Q2'23 to Q1'26, total operating expenses exhibited an overall upward trend, rising from $1.21B USD to $1.68B USD, with R&D expenses showing consistent growth from $451M USD to $638M USD and occasional quarterly fluctuations, while SG&A expenses grew from $761M USD to $1.05B USD but displayed volatility, including a sharp spike to $1.63B USD in Q4'23 and $1.11B USD in Q4'25. This pattern highlights escalating cost pressures, particularly in R&D, amid stable but uneven SG&A dynamics in a stacked bar visualization.